We are pulmonary hypertension (PH) professionals united in our vision for a world without pulmonary vascular disease (PVD). We believe we can achieve this together, and we won’t stop until we do.
PVRI 2026 Awards — Nominations now open
Help us celebrate excellence in PH research and care. PVRI members can now nominate colleagues for our 2026 Awards, to be presented at the Gala Dinner in Dublin. Deadline is 1 December 2025.
Our PVRI Digital Webinar Series alternates between 'Cutting Edge Innovation in Clinical & Experimental PH' and 'Living Legends in PH: History & Personal Perspectives' sessions. Don't miss out!
This November, we’re coming together as one global team to shine a light on PH research and innovation during PH Awareness month through our new fundraising challenge: Breath Beyond Borders. PVRI friends across the world are taking on a personal challenge that pushes their limits. Find out how you can get involved.
Join us 28 January – 1 February as we celebrate 20 years of progress and innovation in PH. This year’s programme highlights advances in PAH, CTEPH, and PH in lung disease, with sessions on emerging therapies, precision medicine, and future directions.
Webinar presentations: A brief introduction to clinical features of PH in BPD; BPD-associated PH: Current evaluation and therapies; BPD-PH: understudied and undertreated- the need for novel interventions; Challenges in designing and implementing multicenter trials: A real world perspective on studies of preterm infants
'Microbes/Parasites and Sex Differences in PVDs' is part of the Virtual Symposium Series by the iPVD, a global education programme that highlights top-notch research on inflammation and infectious PVD.
The resistance–compliance (RC) relationship between pulmonary vascular resistance (PVR) and pulmonary arterial compliance (PAC) provides an integrative measure of global right ventricular (RV) afterload. However, debate persists regarding the clinical utility of PAC calculated using the empiric formula (PACempiric), and the ideal method for calculating PAC.
It was a Sunday morning. That was the only time Drs. Pat Daily or Walt Dembitsky could review cases before they operated on Monday. It was 1986, and I was a pulmonary fellow, so my presence at this meeting with Dr. Kenneth Moser (1929–1997) (Figure 1) was as an observer, not a participant.
In 1988, I had spent over 2 years at the Physiological Institute, working on the competition between skin- and muscle blood flow for cardiac output in man during exercise, when I started my residency in Internal Medicine. There I met Werner Seeger, who was a consultant and was directing the Intensive Care Unit at that time. He enrolled me in his research group, which focused on acute respiratory stress syndrome (ARDS), a condition characterised by a ventilation-perfusion mismatch that results in competition for blood flow between well- and poorly ventilated lung areas, a topic I had previously explored in my scientific work.
These annual awards are given in recognition of outstanding contributions to the field of pulmonary hypertension. They celebrate notable achievements made by special individuals across the world. The PVRI Lifetime Achievement Award 2025, the PVRI Achievement Awards 2025 and the PVRI Special Recognition Award will be presented at PVRI 2026 Dublin.
We’re excited to announce the relaunch of the PVRI Digital Webinar Series, beginning September 2025. This free monthly series, open to all, brings together the global PH community for keynote presentations, rich discussion, and the opportunity to learn cutting-edge new research.
This PH Awareness Month, we’re inviting you to join the global PVRI community for our very first Breath Beyond Borders challenge. Throughout November, PVRI members and friends around the world will be taking on personal challenges — walking, running, cycling, speed skating, or even playing the piano — to shine a light on PH research and innovation, and raise funds for PVRI along the way.
Our Pulmonary Hypertension Global Patient Survey (PHGPS), the largest survey to date to explore the perspectives of patients with PH at a global scale, has released initial findings from its adult cohort of 3,329 patients living with PH.
